Abstract
Skin lesions caused by allergic contact dermatitis are an important occupational and environmental disease. Patch testing is the gold-standard procedure used to diagnose allergic contact dermatitis.
The present chapter summarizes aspects of patch testing for the diagnosis of contact allergy: important working definitions, relevance of treating contact dermatitis, materials, technique, test result and interpretation, and special consideration regarding individual factors which influence the patch test outcome or necessitate special attention.
Performing and interpreting patch tests requires know-how. Knowing how to perform them and the particularities of specific cases is essential to correctly interpret the results. A correct evaluation and diagnosis will significantly impact the natural history of the disease and significantly improve the quality of life of the patient.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anveden I, Lindberg M, Andersen KE, Bruze M, Isaksson M, Liden C et al (2004) Oral prednisone suppresses allergic but not irritant patch test reactions in individuals hypersensitive to nickel. Contact Dermatitis. 50(5):298–303
Beattie PE, Green C, Lowe G, Lewis-Jones MS (2007) Which children should we patch test? Clin Exp Dermatol. 32(1):6–11
Bellegrandi S, Rosso R, Mattiacci G, Ferrara R, D'Offizi G, Aiuti F et al (1999) Contact dermatitis in subjects infected with HIV type 1. J Am Acad Dermatol. 40(5 Pt 1):777–779
Belloni Fortina A, Cooper SM, Spiewak R, Fontana E, Schnuch A, Uter W (2015) Patch test results in children and adolescents across Europe. Analysis of the ESSCA Network 2002-2010. Pediatr Allergy Immunol. 26(5):446–455
Belloni Fortina A, Fontana E, Peserico A (2016) Contact sensitization in children: a retrospective study of 2,614 children from a single center. Pediatr Dermatol. 33(4):399–404
Bennike NH, Heisterberg MS, White IR, Mahler V, Silvestre-Salvador JF, Giménez-Arnau A et al (2019) Quality of life and disease severity in dermatitis patients with fragrance allergy – a cross-sectional European Questionnaire Study. Contact Dermatitis 81(2):89–96
Braunberger T, Lynn D, Reimer C, Doctor M, Hill MK, Mounessa J et al (2016) Disease severity and quality of life measurements in contact dermatitis: a systematic review 2005-2015. Dermatitis 27(6):362–371
Castelain PY, Castelain M, Vervloet D, Garbe L, Mallet B (1988) Sensitization to aluminium by aluminium-precipitated dust and pollen extracts. Contact Dermatitis. 19(1):58–60
Chen JK, Jacob SE, Nedorost ST, Hanifin JM, Simpson EL, Boguniewicz M et al (2016) A pragmatic approach to patch testing atopic dermatitis patients: clinical recommendations based on expert consensus opinion. Dermatitis. 27(4):186–192
Condie MW, Adams RM (1973) Influence of oral prednisone on patch-test reactions to Rhus antigen. Arch Dermatol 107:540–543
Curr N, Nixon R (2006) Allergic contact dermatitis to basic red 46 occurring in an HIV-positive patient. Australas J Dermatol. 47(3):195–197
Dermendzhiev S, Ivanovska M, Dermendzhiev T (2018) Allergic contact dermatitis, angioneurotic edema and conjunctivitis in a patient with autoimmune thrombocytopenia – a clinical case. Open Access Maced J Med Sci. 6(11):2142–2146
Engkilde K, Menné T, Johansen JD (2006) Inverse relationship between allergic contact dermatitis and type 1 diabetes mellitus: a retrospective clinic-based study. Diabetologia. 49(4):644–647
Feuerman E, Levy A (1972) A study of the effect of prednisone and an antihistamine on patch test reactions. Br J Dermatol 86:68–71
Fisher AA, Rietschel RL, Fowler JF, Fisher AA (2008) Fisher’s contact dermatitis. BC Decker Inc, Hamilton
Fonacier L (2015) A practical guide to patch testing. J Allergy Clin Immunol Pract. 3(5):669–675
Fullerton A, Serup J (1997) Characterization of irritant patch test reactions to topical D vitamins and all-trans retinoic acid in comparison with sodium lauryl sulphate. Evaluation by clinical scoring and multiparametric non-invasive measuring techniques. Br J Dermatol. 137(2):234–240
García-Patos V, Pujol RM, Alomar A, Cisteró A, Curell R, Fernández-Figueras MT et al (1995) Persistent subcutaneous nodules in patients hyposensitized with aluminum-containing allergen extracts. Arch Dermatol. 131(12):1421–1424
Green C (1996) The effect of topically applied corticosteroid on irritant and allergic patch test reactions. Contact Dermatitis 35:331–333
Greenspan A, Loesche C, Vendetti N, Georgeian K, Gilbert R, Poncet M et al (2003) Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations. Cutis. 72(1):76–81
Güner E, Kalkan G, Meral E, Baykır M (2013) The triggering role of allergic contact dermatitis in discoid lupus erythematosus. Cutan Ocul Toxicol. 32(3):194–199
Hamann CR, Hamann D, Egeberg A, Johansen JD, Silverberg J, Thyssen JP (2017) Association between atopic dermatitis and contact sensitization: a systematic review and meta-analysis. J Am Acad Dermatol. 77(1):70–78
Herman A, de Montjoye L, Tromme I, Goossens A, Baeck M (2018) Allergic contact dermatitis caused by medical devices for diabetes patients: a review. Contact Dermatitis. 79(6):331–335
Jacob SE, Admani S, Herro EM (2014) Invited commentary: recommendation for a north american pediatric patch test series. Curr Allergy Asthma Rep. 14(6):444
Jacob SE, Lipp MB, Suh E, Goldenberg A (2017) Practice patterns of dermatologists in the pediatric contact dermatitis registry. Pediatr Dermatol. 34(4):408–412
Jappe U, Geier J, Hausen BM (2005) Contact vitiligo following a strong patch test reaction to triglycidyl-p-aminophenol in an aircraft industry worker: case report and review of the literature. Contact Dermatitis. 53(2):89–92
Johansen JD, Aalto-Korte K, Agner T, Andersen KE, Bircher A, Bruze M et al (2015) European Society of Contact Dermatitis guideline for diagnostic patch testing – recommendations on best practice. Contact Dermatitis. 73(4):195–221
Jolanki R, Kanerva L, Estlander T, Henriks-Eckerman ML, Suhonen R (2001) Allergic contact dermatitis from phenoxyethoxy ethylacrylates in optical fiber coating, and glue in an insulin pump set. Contact Dermatitis. 45(1):36–37
Kosboth M, Chin-Loy A, Lyons R, Wesson SK, Reeves WH (2007) Malar rash caused by metal allergy in a patient with systemic lupus erythematosus. Nat Clin Pract Rheumatol. 3(4):240–245
Kostner L, Anzengruber F, Guillod C, Recher M, Schmid-Grendelmeier P, Navarini AA (2017) Allergic contact dermatitis. Immunol Allergy Clin North Am. 37(1):141–152
Kwok C, Wilkinson M, Sommer S (2011) A rare case of acquired leukoderma following patch testing with an acrylate series. Contact Dermatitis. 64(5):292–294
Lazzarini R, Duarte I, Ferreira AL (2013) Patch tests. An Bras Dermatol. 88(6):879–888
Le Coz CJ, Sasseville D (2009) Interpretation and relevance of patch testing: false-positive and false-negative test reactions, compound allergy, cross-sensitivity. Ann Dermatol Venereol. 136(8-9):610–616
Lee JH, Ahn BJ, Noh M, Lee AY (2014) Patch test reactions in patients with the additional diagnosis of vitiligo. Int J Dermatol. 53(2):187–191
Lim HW, Collins SAB, Resneck JS Jr, Bolognia JL, Hodge JA, Rohrer TA et al (2017) The burden of skin disease in the United States. J Am Acad Dermatol 76(5):958–972.e952
Mortz CG, Andersen KE, Dellgren C, Barington T, Bindslev-Jensen C (2015) Atopic dermatitis from adolescence to adulthood in the TOACS cohort: prevalence, persistence and comorbidities. Allergy. 70(7):836–845
Muñoz-Pérez MA, García-Bravo B, Rodriguez-Pichardo A, Camacho F (1999) Coexistence of allergic contact dermatitis and granuloma annulare in an HIV-1-infected patient: a casual association? Am J Contact Dermat. 10(2):100–101
Netterlid E, Hindsén M, Siemund I, Björk J, Werner S, Jacobsson H et al (2013) Does allergen-specific immunotherapy induce contact allergy to aluminium? Acta Derm Venereol. 93(1):50–56
Niedziela M, Bluvshteyn-Walker S (2012) Autoimmune thyroid disease and allergic contact dermatitis: two immune-related pathologies in the same patient. J Pediatr Endocrinol Metab. 25(1-2):31–32
Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF (2009) Allergic and irritant contact dermatitis. Eur J Dermatol. 19(4):325–332
O’Quinn SE, Isbell KH (1969) Influence of oral prednisone on eczematous patch test reactions. Arch Dermatol 99:380–389
Olupona T, Scheinman P (2008) Successful patch testing despite concomitant low-dose prednisone use. Dermatitis. 19(2):117–118
Owen JL, Vakharia PP, Silverberg JI (2018) The role and diagnosis of allergic contact dermatitis in patients with atopic dermatitis. Am J Clin Dermatol. 19(3):293–302
Passanisi S, Lombardo F, Barbalace A, Caminiti L, Panasiti I, Crisafulli G et al (2018) Allergic contact dermatitis and diabetes medical devices: 2 clinical cases. Contact Dermatitis 79(2):115–117
Patel A, Burns E, Burkemper NM (2018) Methotrexate use in allergic contact dermatitis: a retrospective study. Contact Dermatitis. 78(3):194–198
Peeters C, Herman A, Goossens A, Bruze M, Mowitz M, Baeck M (2017) Allergic contact dermatitis caused by 2-ethyl cyanoacrylate contained in glucose sensor sets in two diabetic adults. Contact Dermatitis. 77(6):426–429
Phillips GS, Freites-Martinez A, Hsu M, Skripnik Lucas A, Barrios DM, Ciccolini K et al (2018) Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients. J Am Acad Dermatol. 78(6):1102–1109
Pigatto P, Cesarani A, Barozzi S, Guzzi G (2008) Positive response to nickel and azathioprine treatment. J Eur Acad Dermatol Venereol. 22(7):891
Puza CJ, Atwater AR (2018) Positive patch test reaction in a patient taking dupilumab. Dermatitis. 29(2):89
Ramirez F, Chren MM, Botto N (2017) A review of the impact of patch testing on quality of life in allergic contact dermatitis. J Am Acad Dermatol. 76(5):1000–1004
Rosmarin D, Gottlieb AB, Asarch A, Scheinman PL (2009) Patch-testing while on systemic immunosuppressants. Dermatitis. 20(5):265–270
Rundle CW, Bergman D, Goldenberg A, Jacob SE (2017) Contact dermatitis considerations in atopic dermatitis. Clin Dermatol. 35(4):367–374
Skoet R, Zachariae R, Agner T (2003) Contact dermatitis and quality of life: a structured review of the literature. Br J Dermatol. 149(3):452–456
Smeenk G (1975) Influence of local triamcinolone acetonide on patch test reactions to nickel sulphate. Dermatologica 150:116–121
Smith KJ, Skelton HG, Nelson A, Wagner KF, Hackley BE Jr (1997) Preservation of allergic contact dermatitis to poison ivy (urushiol) in late HIV disease. The implications and relevance to immunotherapy with contact allergens. Dermatology. 195(2):145–149
Spornraft-Ragaller P, Schnuch A, Uter W (2011) Extreme patch test reactivity to p-phenylenediamine but not to other allergens in children. Contact Dermatitis. 65(4):220–226
Spornraft-Ragaller P, Kämmerer E, Gillitzer C, Schmitt J (2012) Severe allergic reactions to para-phenylenediamine in children and adolescents: should the patch test concentration of PPD be changed? J Dtsch Dermatol Ges. 10(4):258–264
Sukanto H, Nater JP, Bleumink E (1981) Influence of topically applied corticosteroids on patch test reactions. Contact Dermatitis 7:180–185
Sulzberger MB, Witten VH, Zimmerman EH (1952) The effects of oral cortisone acetate on patch test reactions to eczematogenous contact allergens. Acta Derm Venereol Suppl (Stockh) 29:343–352
Swietlik J, Reeder M (2016) Current Quality-of-Life Tools Available for Use in Contact Dermatitis. Dermatitis. 27(4):176–185
Tan CH, Rasool S, Johnston GA (2014) Contact dermatitis: allergic and irritant. Clin Dermatol. 32(1):116–124
Tasic T, Bäumer W, Schmiedl A, Schwichtenhövel F, Pabst R, Raap U et al (2011) Dipeptidyl peptidase IV (DPP4) deficiency increases Th1-driven allergic contact dermatitis. Clin Exp Allergy. 41(8):1098–1107
Tennstedt D (2009) Patch tests: indications or when testing should be performed. Ann Dermatol Venereol. 136(8-9):579–583
Trindade MA, Alchorne AO, da Costa EB, Enokihara MM (2004) Eyelid discoid lupus erythematosus and contact dermatitis: a case report. J Eur Acad Dermatol Venereol. 18(5):577–579
Verma KK, Mahesh R, Bhari N, Pandey RM (2016a) Effect of betamethasone on patch test reactivity in patients with parthenium dermatitis. Contact Dermatitis. 75(3):193–194
Verma KK, Bhari N, Sethuraman G (2016b) Azathioprine does not influence patch test reactivity in Parthenium dermatitis. Contact Dermatitis. 74(1):64–65
Viraben R, Aquilina C, Cambon L, Bazex J (1994) Allergic contact dermatitis in HIV-positive patients. Contact Dermatitis. 31(5):326–327
Vogelbruch M, Nuss B, Körner M, Kapp A, Kiehl P, Bohm W (2000) Aluminium-induced granulomas after inaccurate intradermal hyposensitization injections of aluminium-adsorbed depot preparations. Allergy. 55(9):883–887
Waard-van der Spek FB, Andersen KE, Darsow U, Mortz CG, Orton D, Worm M et al (2013) Allergic contact dermatitis in children: which factors are relevant? (Review of the literature). Pediatr Allergy Immunol. 24(4):321–329
Waard-van der Spek FB, Darsow U, Mortz CG, Orton D, Worm M, Muraro A et al (2015) EAACI position paper for practical patch testing in allergic contact dermatitis in children. Pediatr Allergy Immunol. 26(7):598–606
Wee JS, White JM, McFadden JP, White IR (2010) Patch testing in patients treated with systemic immunosuppression and cytokine inhibitors. Contact Dermatitis. 62(3):165–169
Worm M, Aberer W, Agathos M, Becker D, Brasch J, Fuchs T et al (2007) Patch testing in children--recommendations of the German Contact Dermatitis Research Group (DKG). J Dtsch Dermatol Ges. 5(2):107–109
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Marcelino, J., Giménez-Arnau, A.M. (2021). Contact Dermatitis: Overcoming Challenges of Specific Patients, Deciphering the Results and Reaching a Correct Diagnosis. In: Traidl-Hoffmann, C., Zuberbier, T., Werfel, T. (eds) Allergic Diseases – From Basic Mechanisms to Comprehensive Management and Prevention . Handbook of Experimental Pharmacology, vol 268. Springer, Cham. https://doi.org/10.1007/164_2021_481
Download citation
DOI: https://doi.org/10.1007/164_2021_481
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-84047-1
Online ISBN: 978-3-030-84048-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)